CT Quantitative Assessment of Interstitial Lung Disease

Recruiting now

Conditions studied: Interstitial Lung Disease

In brief

Interstitial lung disease (ILD) refers to a broad category of heterogeneous lung diseases with different etiologies and features characterized by inflammation and fibrosis of the lung parenchyma and manifested as exertional dyspnea, interstitial patterns on high resolution computed tomography (HRCT), and abnormal pulmonary function tests (PFTs) The aim of this study is to investigate is there any correlation between changes seen in the lung parenchyma by HRCT and the pulmonary functions of the patients.

Key facts

Study ID

NCT05947422

Run by

Assiut University

People needed

70

Starts

2023-12-01

Expected to finish

2025-12-30

Last updated by the study team

2025-05-01

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of ILD (based on clinical, radiological, and pulmonary function criteria +/- histopathological criteria).
• Availability of CT chest DICOM images and pulmonary function test results (within a 2-weeks period from each other).

You may not qualify if…

• Pregnancy
• Pulmonary edema.
• Primary pulmonary hypertension;
• Chronic obstructive pulmonary disease
• Congestive heart failure

Where it is running

• Assiut University Hospital — Asyut, Asyut Governorate, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.